Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone marrow transplantation for MDS].

N Inoue1, Y Takemoto, T Okamoto

  • 1Second Department of Internal Medicine, Hyogo College of Medicine.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|September 1, 1990
PubMed
Summary

Bone marrow transplantation (BMT) shows promise for myelodysplastic syndromes (MDS), particularly for refractory anemia (RA) with poor prognostic factors. Further research is needed to optimize outcomes and reduce transplant-related mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Herpesvirus Infection in Patients Following Bone Marrow Transplantation: Influence of Viral Reactivation on Prognosis.

Hematology (Amsterdam, Netherlands)·2016
Same author

Exogenous PML/RARα Fusion Gene Responds to All-trans Retinoic Acid Results in Differentiation of the Human B Cell Line.

Hematology (Amsterdam, Netherlands)·2016
Same author

Similarity Between Multiple Sclerosis and Idiopathic Central Nervous System Dysfunction After Bone Marrow Transplantation.

Hematology (Amsterdam, Netherlands)·2016
Same author

Cytokines and Cytomegalovirus Disease Following Allogeneic Bone Marrow Transplantation.

Hematology (Amsterdam, Netherlands)·2016
Same author

Acute Colonic Graft-versus-host Disease and Ulcerative Colitis with Respect to Cytokines.

Hematology (Amsterdam, Netherlands)·2016
Same author

A Case of Minimally Differentiated Acute Leukemia (AML-M0) Complicated by Ventricle Thrombosis During Remission-induction.

Hematology (Amsterdam, Netherlands)·2016

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
  • Treatment options for MDS are limited, especially for high-risk subtypes.
  • Bone marrow transplantation (BMT) is a potential curative therapy for MDS.

Observation:

  • Five patients with MDS (4 RA, 1 RAEB-T) underwent myeloablative conditioning followed by BMT.
  • All patients received cyclophosphamide and total body irradiation for conditioning.
  • Engraftment was achieved in all patients, but treatment-related mortality occurred.

Findings:

  • One patient died from intracranial hemorrhage due to refractory thrombocytopenia.
  • Another patient died from respiratory failure secondary to interstitial pneumonia.

Related Experiment Videos

  • One patient experienced graft failure and received a second BMT without conditioning.

    • Implications:

    • BMT may be a viable treatment option for MDS, particularly for RA with adverse prognostic factors.
    • Strategies to mitigate BMT-related complications, such as infections and graft failure, are crucial.
    • Further investigation is warranted to refine BMT protocols for MDS patients.